Preschool Attention-Deficit/Hyperactivity Disorder and Telephone Medication Management at Developmental-Behavioral

Elizabeth Harstad1, Justine Shults2, William Barbaresi1

  • 1Division of Developmental Medicine, Boston Children's Hospital, Boston, MA.

Insights

Developmental-behavioral pediatricians use telephone encounters for preschool ADHD medication management, with significant site variation. This highlights the important role of telehealth in pediatric ADHD care.

Area of Science:

  • Pediatrics
  • Behavioral Science
  • Pharmacology

Background:

  • Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in preschoolers.
  • Medication management is a key component of ADHD treatment.
  • Developmental-behavioral pediatricians (DBPs) are specialists in managing complex pediatric behavioral and developmental disorders.

Purpose of the Study:

  • To investigate the utilization of clinic versus telephone encounters by DBPs for managing preschooler ADHD medication.
  • To understand patterns and variations in telehealth use for ADHD pharmacotherapy in young children.

Main Methods:

  • Retrospective analysis of medical records from 503 children younger than 72 months treated for ADHD.
  • Data abstracted on medication treatment episodes and encounter types (clinic vs. telephone) across 7 DBP sites.
  • Descriptive statistics and chi-squared analyses were employed.

Main Results:

  • Initial ADHD medication was started via clinic (85.9%) more often than telephone (14.1%) encounters.
  • Dose/frequency reductions were less common in clinic vs. telephone encounters (27% vs. 73%).
  • Adding medication was more frequent in clinic vs. telephone encounters (64% vs. 36%).
  • Significant variation in telephone encounter frequency (16.9%–68.9%) was observed across sites.

Conclusions:

  • Telephone encounters are utilized to varying degrees for preschool ADHD pharmacologic management across DBP sites.
  • Telehealth plays a significant role in the delivery of ADHD care for young children.
  • Findings can inform best practices for telehealth in pediatric ADHD management.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
508
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
64
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
218
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
136
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
57
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
71